JTJohn M. Thorp

John M. Thorp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John M. Thorp has a total of 186 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chorionic vascular “fit” in the human placenta: Relationship to fetoplacental outcomes

    by Carolyn M. Salafia, Ruchit G. Shah, Dawn P. Misra, Jennifer K. Straughen, Drucilla J. Roberts, Larry Troxler, Simon P. Morgan, Barbara Eucker, John M. Thorp


  • Antenatal Betamethasone for Women at Risk for Late Preterm Delivery

    by Cynthia Gyamfi-Bannerman, Elizabeth A. Thom, Sean C. Blackwell, Alan T. N. Tita, Uma M. Reddy, George R. Saade, Dwight J. Rouse, David S. McKenna, Erin A. S. Clark, John M. Thorp, et al.


  • Does the Presence of a Condition-Specific Obstetric Protocol Lead to Detectable Improvements in Pregnancy Outcomes?

    by Jennifer L. Bailit, William A. Grobman, Paula McGee, Uma M. Reddy, Ronald J. Wapner, Michael W. Varner, John M. Thorp, Kenneth J. Leveno, Jay D. Iams, Alan T. N. Tita, et al.

    In attempt to improve patient safety and outcomes, protocols for treatment of a specific complication have been suggested in various studies and encouraged by government regulation and malpractice carriers. However, evidence that condition-specific protocols improve obstetric outcomes is lacking. Studies that have shown improved outcomes because of these protocols have been primarily limited to single centers. This study examined if risk-adjusted patient outcomes would be better in hospitals with condition-specific obstetric protocols in place compared with hospitals without protocols. This study was a secondary analysis of the data set from a cohort study at 25 hospitals that was performed between 2008 and 2011, the Assessment of Perinatal Excellence (APEX) study. Participating hospitals submitted all protocols for labor and delivery quarterly and included the dates that those protocol were in effect. Patients were categorized by whether they delivered in the presence of a protocol. Data were analyzed to find whether the outcomes, adjusted for risk, related to specific complications were associated with condition-specific protocols used during deliver. Data from 115,502 patients were collected. The rate of hemorrhage was significantly higher in hospitals with a hemorrhage protocol. Hospitals without preeclampsia protocols had significantly higher rates of intensive care unit admissions for preeclampsia (odds ratio, 0.28; 95% confidence interval, 0.18–0.44), and preeclampsia-specific protocols were also associated with fewer cases of severe hypertension (odds ratio, 0.86; 95% confidence interval, 0.77–0.96). Protocols for postpartum hemorrhage were associated with an increased rate of postpartum hemorrhage and not associated with a lower rate of cases with more than 1000-mL estimated blood loss. Protocols for shoulder dystocia were not associated with a change in the rate of shoulder dystocia or rate of shoulder dystocia maneuvers used. There was not a consistent relationship found between condition-specific protocols and the severity of those complications. The adjustment for risk in these data was important for determining results. The different results found between preeclampsia protocols and hemorrhage protocols may be explained by the fact that preeclampsia is a more frequently occurring complication, and providers may be more familiar with that protocol. In conclusion, the results suggest whether a protocol is in place does not matter. More research is necessary to better understand high-quality protocol.


  • Activity Restriction Among Women With a Short Cervix

    by William A. Grobman, Sharon A. Gilbert, Jay D. Iams, Catherine Y. Spong, George Saade, Brian M. Mercer, Alan T. N. Tita, Dwight J. Rouse, Yoram Sorokin, Kenneth J. Leveno, et al.

    Preterm birth remains a leading cause of perinatal morbidity and mortality, and prophylactic and therapeutic strategies have not reduced its frequency. Activity restriction specifically has not been beneficial and is associated with adverse social, economic, and health outcomes. This present secondary analysis of data from the Short Cervix and Nulliparity Trial was designed to estimate the determinants and outcomes of activity restriction in parturients with a short cervix. In the original randomized placebo-controlled trial, asymptomatic nulliparous women with singleton gestations and cervices of less than 30 mm received either weekly intramuscular 17-α hydroxyprogesterone caproate or placebo. During the weekly study visits, participants were asked whether pelvic rest (no sexual activity), reduction of work activity, or reduction of nonwork activity had been recommended. Women who had reductions in either pelvic, work, or nonwork activity were considered as having had “any” activity restriction. The association between activity restriction and preterm birth was determined at less than 37 and less than 34 weeks’ gestation. Multivariable analyses were performed with multiple logistic regression with odds ratios (ORs), adjusted ORs (aORs), and 95% confidence intervals (CIs) reported. All tests were 2 tailed, and P < 0.05 defined statistical significance. All analyses were performed with SAS version 9.2. Of the 657 women in the randomized trial, 646 (98%) responded to questions regarding activity restriction. Nearly 40% of women with a short cervix were placed on some activity restriction, usually in the midsecond to early third trimester, soon after the diagnosis of a short cervix was made. In 171 (68%) of 252 patients, all 3 types of activity restriction were combined. Compared with women without activity restriction, women who received recommendations for activity restriction were older (P < 0.001), more likely to have private insurance (P = 0.01), and less likely to be Hispanic white (P < 0.001); they also had shorter cervical lengths and were more likely to have cervical funneling or intra-amniotic debris. Preterm birth at less than 37 weeks’ gestation was significantly more common among women placed on any activity restriction (37% vs 17%, P < 0.001; OR, 2.91; 95% CI, 2.0–4.21). No significant interactions were found between activity restriction and treatment with 17-α hydroxyprogesterone caproate, cervical length of less than 15 mm, or gestational age at screening. After controlling for treatment group and demographic and ultrasonographic differences among those with and without activity restriction, preterm birth at less than 37 or less than 34 weeks’ gestation remained significantly more common among those placed on any activity restriction (aOR, 2.37; 95% CI 1.60–3.53 and aOR, 2.28, 95% CI, 1.36–3.80, respectively). Results were similar when only women prescribed limitation of work and nonwork activities were included in the restriction group (<37 weeks’ gestation: aOR, 2.44; 95% CI, 1.63–3.65; <34 weeks gestation: aOR, 2.70; 95% CI, 1.62–4.52). Some form of activity restriction was prescribed for more than 1 in every 3 nulliparous women with a short cervix. Activity restriction affected patients’ work and home life, and yet, they were still significantly more likely to deliver preterm. Activity restriction has been associated with increased stress and anxiety and increased chances of venous thromboembolism, bone loss, deconditioning, and financial difficulties. These complications and risk of preterm birth suggest that this intervention should be proven beneficial before it is used routinely for preterm birth prophylaxis.

  • Failed Labor Induction Toward an Objective Diagnosis

    by Dwight J. Rouse, Steven J. Weiner, Steven L. Bloom, Michael W. Varner, Catherine Y. Spong, Susan M. Ramin, Steve N. Caritis, William A. Grobman, Yorom Sorokin, Anthony Sciscione, et al.


  • A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy

    by Dwight J. Rouse, Deborah G. Hirtz, Elizabeth Thom, Michael W. Varner, Catherine Y. Spong, Brian M. Mercer, Jay D. Iams, Ronald J. Wapner, Yoram Sorokin, James M. Alexander, et al.

    Early preterm birth is associated with approximately one third of all cases of cerebral palsy and is a risk factor. A case–control study was the first to show a decrease in the incidence of cerebral palsy in the offspring of women who were given magnesium sulfate before preterm delivery. This randomized, placebo-controlled, double-blind trial tested the hypothesis that antenatal administration of magnesium sulfate would reduce the incidence of cerebral palsy in the children of women at high risk for early preterm delivery. At 20 sites across the United States from December 1997 through May 2004, 2241 women at high risk for spontaneous delivery at 24 through 31 weeks’ gestation were randomized to receive either intravenous magnesium sulfate (6 gm infusion for 20 to 30 minutes followed by a maintenance infusion of 2 gm per hour) or a placebo. The primary outcome was the composite of stillbirth or infant death by 1 year of age or moderate or severe cerebral palsy at or beyond 2 years of age. A trained psychologist or psychometrist administered and assessed scores on the Bayley Scales of Infant Development II. Baseline characteristics of the two groups were matched. Over 95% of the children were followed for 24 months. Corrections were made for prematurity. No significant differences were found for the primary composite outcome of moderate or severe cerebral palsy or death in the offspring of the magnesium sulfate group and the placebo group (11.3 versus 11.7%; relative risk, 0.97; 95% confidence interval [CI], 0.77 to 1.23; P = .80). However, women in the magnesium sulfate group had a significantly lower risk of giving birth to an infant who subsequently developed moderate or severe cerebral palsy than women in the placebo group (1.9% versus 3.5%, respectively; relative risk, 0.55; 95% CI, 0.32 to 0.95; P ≤ .03). There was no difference in scores on the Bayley scales of infant development between the two groups. No life threatening maternal events were noted in either group. This study is consistent with previous reports that antenatal magnesium sulfate does not reduce the combined risk of death or moderate or severe cerebral palsy, but may reduce the risk of cerebral palsy among survivors.

  • CONTRIBUTORS

    by Vikki M. Abrahams, Michael J. Aminoff, Marie H. Beall, Kurt Benirschke, Daniel G. Blanchard, Kristie Blum, Patrick Catalano, Christina Chambers, Ronald Clyman, David Cohn, et al.

  • Utilization of Anti-RhD in the Emergency Department After Blunt Trauma

    by John M. Thorp

    In the United States, trauma occurs in 6% to 7% of pregnancies. Its severity may range from critical injuries where the mother's life is at risk, to apparently minor injuries, which might not be associated with any worrisome symptoms. One of the risks associated with a traumatic event is fetomaternal hemorrhage--the transfer of fetal blood cells into the maternal circulation. If the maternal blood type is rhesus negative and the fetus is rhesus positive, even a small amount of blood can cause the mother to develop antibodies against the fetal Rho D antigen, thus becoming sensitized. In subsequent pregnancies, this can lead to hemolytic disease of the fetus or newborn, which, if severe, is associated with total body edema, hepatosplenomegaly and heart failure, and intrauterine death. Although there are no published studies specific to the US population, poor awareness of the risk of sensitization following trauma and underutilization of anti-RhD in the emergency department has been reported in countries such as Canada and the United Kingdom. This article reminds caregivers of the risk of rhesus sensitization following blunt trauma, in order that they can administer anti-RhD appropriately and hemolytic disease of the fetus or newborn can be prevented.


  • Long-Term Outcomes After Repeat Doses of Antenatal Corticosteroids

    by Ronald J. Wapner, Yoram Sorokin, Lisa Mele, Francee Johnson, Donald J. Dudley, Catherine Y. Spong, Alan M. Peaceman, Kenneth J. Leveno, Fergal Malone, Steve N. Caritis, et al.